glp 1 and heart health Cardiovascular disease continuum-GLP-1 action. Adapted from [46] GLP-1 Medications and Heart Health
Description
Exendin4 decreases amphetamineinduced locomotor activity
has also received CME-related honoraria or consulting fees from CASEN Recordati, Organon, Lundbeck, and the Academy for Continuing Medical Education (Akademijazakme), with no financial or other conflicts of interest relevant to the subject of this article
![glp 1 and heart health Cardiovascular disease continuum-GLP-1 action. Adapted from [46] GLP-1 Medications and Heart Health](https://www.mdpi.com/jcm/jcm-14-06758/article_deploy/html/images/jcm-14-06758-g001.png)
Mol Endocrinol 28: 18551865
In an extension of the STEP-1 trial, participants originally randomized to semaglutide regained 68% of their lost weight after one year of discontinuing treatment
![glp 1 and heart health Cardiovascular disease continuum-GLP-1 action. Adapted from [46] GLP-1 Medications and Heart Health](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/ffd4/12904707/4fa38c7b0690/jci-136-194748-g202.jpg)
Abnormalities in the genioglossus muscle and its neuromuscular synapse in leptin-deficient male mice
![glp 1 and heart health Cardiovascular disease continuum-GLP-1 action. Adapted from [46] GLP-1 Medications and Heart Health](https://passionhealthphysicians.com/wp-content/uploads/2026/06/ChatGPT-Image-Jun-10-2026-01_08_15-PM.png)
Contact us today to schedule your free consultation
![glp 1 and heart health Cardiovascular disease continuum-GLP-1 action. Adapted from [46] GLP-1 Medications and Heart Health](https://ars.els-cdn.com/content/image/1-s2.0-S2095177923002903-ga1.jpg)